Image

PGHD-AI Intelligent Model for the Nutritional Assessment and Intervention of Patients After Radical Surgery for Pancreatic Cancer.

Nutritional Assessment for Pancreatic Cancer Surgery Patients

Recruiting
18-80 years
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the nutritional assessment and intervention for patients after radical surgery for pancreatic cancer. The purpose of this study is to evaluate the use of patient-generated health data (PGHD) and artificial intelligence (AI) in assessing nutritional risks.

The study focuses on the feasibility of using AI to predict health status and provide nutritional support evaluation. It evaluates the effectiveness of these methods in managing pancreatic cancer patients' health and improving their quality of life.

  • Who can participate: Adults aged 18 to 80 who have undergone radical surgery for pancreatic cancer and meet clinical diagnostic criteria are eligible. Participants must have an ECOG score of 0-1.
  • Study details: Participants will use an app to manage their health data and undergo routine follow-ups. The study includes a control group and a test group to compare nutritional status predictions.
  • Study timelines: The study will last 1 year.
Print
Study details
    Pancreatic Cancer

NCT07167264

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.